Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction

NCT06883396

Conditions
Disease Attributes, Fractures, Bone, Joint Diseases, +16 more
Locations
  • Stanford University Redwood City, California, United States
  • University of Florida Gainesville, Florida, United States
  • Midwest Orthopaedics at Rush Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View all 16 locations
View Trial Details
Recruiting

Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial

NCT07263438

Conditions
Astrocytoma, Disease Attributes, Glioblastoma, +12 more
Locations
  • Universitätsspital Basel Basel, Switzerland
  • Kantonsspital Aarau Aarau, Canton of Aargau, Switzerland
  • Bern Inselspital Bern, Canton of Bern, Switzerland
  • HFR Fribourg - Hôpital cantonal Fribourg, Canton of Fribourg, Switzerland
View Trial Details
Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

NCT05079282

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California Irvine Medical Center - Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
View all 20 locations
View Trial Details
Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

NCT06393738

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Detroit, Michigan, United States
  • Clinical Trial Site New Brunswick, New Jersey, United States
  • Clinical Trial Site New York, United States
View all 17 locations
View Trial Details
Recruiting

A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

NCT07105059

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma

NCT06574568

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Beijing Chao-yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Jishuitan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Shunde Hospital of Southern Medical University Foshan, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia

NCT05366218

Conditions
ALL, Childhood B-Cell, Acute Lymphocytic Leukemia Refractory, Acute Lymphoid Leukemia Relapse, +4 more
Locations
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • University childrens Hospital Tübingen, Baden-Wurttemberg, Germany
  • Klinik für Kinder- und Jugendmedizin Ulm, Baden-Wurttemberg, Germany
  • Klinikum Dr. von Haunersches Kinderspital München, Bavaria, Germany
View Trial Details

Related conditions